CircRNAs in lung cancer - Biogenesis, function and clinical implication.

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Lung cancer remains a leading global cause of cancer incidence and mortality.
• The molecular mechanisms driving lung cancer development require further elucidation.
• Non-coding RNAs, including circular RNAs (circRNAs), are implicated in various cancers, but their role in lung cancer is not well understood.

Purpose of the Study:

• To review the biological functions and mechanisms of circRNAs in lung cancer.
• To investigate the role of aberrant circRNA expression in lung cancer progression, including proliferation, invasion, and drug resistance.
• To discuss the potential of circRNAs as clinical biomarkers for lung cancer diagnosis, prognosis, and treatment.

Main Methods:

• Literature review of existing studies on circRNAs in lung cancer.
• Analysis of circRNA expression patterns and their correlation with clinical outcomes.
• Examination of the functional roles of circRNAs in cancer cell behavior and the tumor microenvironment.

Main Results:

• CircRNAs exhibit stable structures and specific expression patterns, making them promising research subjects.
• Aberrant expression of circRNAs is linked to key aspects of lung cancer, such as uncontrolled cell proliferation and metastasis.
• CircRNAs influence drug resistance and modulate the tumor microenvironment in lung cancer.

Conclusions:

• CircRNAs play significant roles in the tumorigenesis and progression of lung cancer.
• Dysregulated circRNAs are potential biomarkers for early diagnosis and predicting patient outcomes in lung cancer.
• Targeting circRNAs may offer novel therapeutic strategies for lung cancer treatment.